Rajkumar JS, Akbar S, Anirudh JR, Prabhakaran R, N Kumaraswamy, Selvamuthu Poongulali, Jayakrishna Reddy and Nabeel Nazeer
Background: People living with HIV infection have a longer survival rate after the introduction of Highly active antiretroviral therapy (HAART). Hence major resections in these patients can be performed safely.
Materials and methods: 5 retro positive patients underwent minimally invasive esophagostomy (MIE) in our institution between 2010 and 2015. Patient demographics, HIV status (CD4 count and viral load), Post-operative mortality, technical feasibility and outcomes were analyzed.
Results: Out of the 5 thoraco-lap esophagectomies, none required conversion. One patient died in the postoperative period due to overwhelming chest infection and sepsis (mortality - 20%). Two patients (40%) required prolonged ventilatory support in the postoperative setting. We had anastomotic leak in one patient (20%), which settled spontaneously. The expired patient carried maximum viral load (1,57,454) and lowest CD4 count (120).
Conclusion: Minimally invasive esophagectomy is a safe and viable option in retro positive patients, wherein the morbidity of laparotomy and thoracotomy are avoided. We report, what we believe is the first pilot case series of 5 minimally invasive esophagectomies in HIV positive patients and we believe that this study will be the shoulders for the next generation of investigators to stand on.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 